You are using an older browser version. Please use a supported version for the best MSN experience.

Lupin launches generic hypertension drug in US market

LiveMint logoLiveMint 04-09-2017 PTI

New Delhi: Drug maker Lupin Ltd on Monday announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US market.

The company has launched the tablets in strengths of 5 mg, 20 mg and 40 mg after having received an approval from the US Food and Drug Administration (FDA) earlier, Lupin said in a statement.

The Mumbai-based company’s product is the generic equivalent of Daiichi Sankyo Inc.’s Benicar tablets which is indicated for the treatment of hypertension. As per IMS MAT data for July 2017, Benicar tablets had US sales of $681 million.

Lupin shares were trading 0.13% down at Rs 992.25 on BSE.

More From LiveMint

image beaconimage beaconimage beacon